{"id":181549,"date":"2026-04-08T16:59:31","date_gmt":"2026-04-08T20:59:31","guid":{"rendered":"https:\/\/alphastreet.com\/india\/jeena-sikho-lifecare-ltd-jsll-q3-2026-earnings-call-transcript\/"},"modified":"2026-04-08T16:59:31","modified_gmt":"2026-04-08T20:59:31","slug":"jeena-sikho-lifecare-ltd-jsll-q3-2026-earnings-call-transcript","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/jeena-sikho-lifecare-ltd-jsll-q3-2026-earnings-call-transcript\/","title":{"rendered":"Jeena Sikho Lifecare Ltd (JSLL) Q3 2026 Earnings Call Transcript"},"content":{"rendered":"

Jeena Sikho Lifecare Ltd (NSE: JSLL) Q3 2026 Earnings Call dated Feb. 09, 2026<\/span><\/strong><\/p>\n

Corporate Participants:<\/h2>\n

Manish Groverji<\/strong> \u2014 Managing Director<\/em><\/p>\n

Nanak Chand<\/strong> \u2014 Chief Financial Officer<\/em><\/p>\n

Analysts:<\/h2>\n

Ranvir Singh<\/strong> \u2014 Analyst<\/em><\/p>\n

Priyanshu Jain<\/strong> \u2014 Analyst<\/em><\/p>\n

Akshay Kaila<\/strong> \u2014 Analyst<\/em><\/p>\n

Abhishek Sengupta<\/strong> \u2014 Analyst<\/em><\/p>\n

Akhilesh Rawat<\/strong> \u2014 Analyst<\/em><\/p>\n

Unidentified Participant<\/strong><\/p>\n

Praveen Kumar<\/strong> \u2014 Analyst<\/em><\/p>\n

Deepak Pruthi<\/strong> \u2014 Analyst<\/em><\/p>\n

Omkar G<\/strong> \u2014 Analyst<\/em><\/p>\n

Amit Jeswani<\/strong> \u2014 Analyst<\/em><\/p>\n

Harish Kumar<\/strong> \u2014 Analyst<\/em><\/p>\n

Pratik Tandel<\/strong> \u2014 Analyst<\/em><\/p>\n

Presentation:<\/h2>\n

Operator<\/strong><\/p>\n

Ladies and gentlemen, good day and welcome to the Jeena Sikho Lifecare Limited Q3 FY26 Earnings Call. As a reminder, all participant lines will be in the listen-only mode and there’ll be an opportunity for you to ask questions after the presentation concludes. [Operator Instructions]<\/p>\n

I now hand the conference over to Mr. Ranvir Singh. Thank you. And over to you.<\/p>\n

Ranvir Singh<\/strong> \u2014 Analyst<\/em><\/p>\n

Yeah. Thank you, moderator. So on behalf of Jeena Sikho Lifecare Limited, I extend very warm welcome to all participants on the Q3 FY26 financial results discussion call. Joining us today on the call are Mr. Manish Grover Ji, popularly known as Acharya Ji, is the Managing Director; Mr. Nanak Chand, is the CFO.<\/p>\n

Before we begin, I would like to draw your attention to the standard disclaimer. This call may contain certain forward-looking statements which are based on management’s current expectations and beliefs. These statements are subject to risks and uncertainties and actual results may differ materially.<\/p>\n

With that, I would now like to hand over the call to Acharya Manish Ji for his opening remarks. Over to you, sir.<\/p>\n

Manish Groverji<\/strong> \u2014 Managing Director<\/em><\/p>\n

[Speech Overlap]<\/p>\n

Nanak Chand<\/strong> \u2014 Chief Financial Officer<\/em><\/p>\n

Thank you, Manish sir. Good afternoon, everyone. I will now take you through the key financial highlights for Q3 FY26 prepared in accordance with the Ind AS following our migration to the main board in August 2025. For the quarter, our revenue from the operation stood INR221.7 crores up by 92% year-to-year and 17% Q-to-Q. Gross profit increased to INR197.5 crores with an improved gross margin 89%.<\/p>\n

Our EBITDA sum will add INR100.8 crores recorded 240% YoY growth with margins at 45%. Profit after tax stood at INR66.7 crores reflecting 405% YoY growth. Our basic EPS for the quarter is 5.37%. The improvement in the profitability was given by the higher operating leverage from the increased patient volume, strong contribution from the high margin products and sales, controlled operating expense despite our network expansion. Our balance sheet remains strong with prudent financial management improving cash flow and capital-light expansion strategies supporting the superior ROCE.<\/p>\n

With this, we open the floor for a question-answer-session. Thank you.<\/p>\n

Questions and Answers:<\/h2>\n

Operator<\/strong><\/p>\n

Thank you. We will now begin the question-and-answer session. [Operator Instructions] We have the first question on the line of Priyanshu Jain from GrowthX Infinity. Please go ahead.<\/p>\n

Priyanshu Jain<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Manish Groverji<\/strong><\/p>\n

[Speech Overlap] Thank you, sir.<\/p>\n

Operator<\/strong><\/p>\n

Thank you. We have the next question from line of Akshay from AK Investment. Please go ahead.<\/p>\n

Akshay Kaila<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Manish Groverji<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Akshay Kaila<\/strong><\/p>\n

[Speech Overlap] Okay, okay. Thank you so much, sir. And all the best.<\/p>\n

Operator<\/strong><\/p>\n

Thank you. [Operator Instructions] We have the next question line of Abhishek Sengupta from AB Capital. Please go ahead.<\/p>\n

Abhishek Sengupta<\/strong><\/p>\n

Hello, am I audible?<\/p>\n

Operator<\/strong><\/p>\n

Yes, we can hear you.<\/p>\n

Abhishek Sengupta<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Manish Groverji<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Operator<\/strong><\/p>\n

Sorry to interrupt you, Mr. Sengupta. Mr. Sengupta, sorry to interrupt you. Request you to kindly come back in queue for follow-up questions.<\/p>\n

Abhishek Sengupta<\/strong><\/p>\n

Okay, okay. Yeah. Thank you.<\/p>\n

Operator<\/strong><\/p>\n

We have the next question from line of Akhilesh Rawat from Ridhanta Vision. Please go ahead.<\/p>\n

Akhilesh Rawat<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Manish Groverji<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Operator<\/strong><\/p>\n

Thank you. We have the next question from the line of Shubhanu [Phonetic] from Three Head Capital. Please go ahead.<\/p>\n

Unidentified Participant<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Manish Groverji<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Operator<\/strong><\/p>\n

Thank you. We have the next question line of Praveen Kumar from Praveen Investments. Please go ahead.<\/p>\n

Praveen Kumar<\/strong><\/p>\n

Hi, sir. Can you hear me?<\/p>\n

Manish Groverji<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Praveen Kumar<\/strong><\/p>\n

Hello, sir. Sir, I have two questions. Can you tell me what percentage of your patients are referring? That’s the first question. And second question is the follow up on your previous comment. You said you are…<\/p>\n

Manish Groverji<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Praveen Kumar<\/strong><\/p>\n

Yes, sir. Can you hear me?<\/p>\n

Manish Groverji<\/strong><\/p>\n

Yes.<\/p>\n

Praveen Kumar<\/strong><\/p>\n

Okay. So my first question is. What is the percentage of recurring the patients?<\/p>\n

Manish Groverji<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Praveen Kumar<\/strong><\/p>\n

Okay, understood. My second question is on your previous comment. You said you have wind up so much of cash and planning for some acquisition or big engagement, right. Can you comment more on that, please? Where are we and what are those plans?<\/p>\n

Manish Groverji<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Praveen Kumar<\/strong><\/p>\n

Understood. All the best, sir. Thank you.<\/p>\n

Operator<\/strong><\/p>\n

Thank you. We have the next question line of Deepak Pruthi from Wealth with Wisdom. Please go ahead.<\/p>\n

Deepak Pruthi<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Manish Groverji<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Operator<\/strong><\/p>\n

Thank you. We have the next question from the line of Omkar G from Shree Investment. Please go ahead.<\/p>\n

Omkar G<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Manish Groverji<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Operator<\/strong><\/p>\n

Thank you. We have the next question from line of Amit Jeswani from Stallion Asset. Please go ahead.<\/p>\n

Amit Jeswani<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Manish Groverji<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Amit Jeswani<\/strong><\/p>\n

I’ll see you, sir. I’ll see you there.<\/p>\n

Manish Groverji<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Amit Jeswani<\/strong><\/p>\n

Thank you, sir. Thank you so much, sir. [Speech Overlap] How will you get there?<\/p>\n

Manish Groverji<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Amit Jeswani<\/strong><\/p>\n

Right, right. So basically…<\/p>\n

Manish Groverji<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Amit Jeswani<\/strong><\/p>\n

Thank you, sir.<\/p>\n

Operator<\/strong><\/p>\n

Thank you. We have the next question from the line of Ankit from Fusion Capital [Phonetic]. Please go ahead.<\/p>\n

Unidentified Participant<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Manish Groverji<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Operator<\/strong><\/p>\n

Thank you. We have the next question from the line of Harish Kumar from Nirmal Bang. Please go ahead.<\/p>\n

Harish Kumar<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Manish Groverji<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Harish Kumar<\/strong><\/p>\n

Thank you, sir.<\/p>\n

Operator<\/strong><\/p>\n

Thank you. We have the next question from the line of Pratik Tandel from Qode Advisors LLP. Please go ahead.<\/p>\n

Pratik Tandel<\/strong><\/p>\n

Hello, am I audible?[Speech Overlap]<\/p>\n

Nanak Chand<\/strong><\/p>\n

Yes, sir. We are maintaining the sale proportion of the product and service as well as government scenarios. Right here, we are maintaining the 3%…<\/p>\n

Pratik Tandel<\/strong><\/p>\n

41% and 54% — yeah.<\/p>\n

Nanak Chand<\/strong><\/p>\n

Yeah. So we are sustained on the same margin.<\/p>\n

Pratik Tandel<\/strong><\/p>\n

Okay.<\/p>\n

Manish Groverji<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Pratik Tandel<\/strong><\/p>\n

Right, okay. Understood. Makes sense. Perfect. Thank you so much.<\/p>\n

Manish Groverji<\/strong><\/p>\n

Thank you, sir.<\/p>\n

Operator<\/strong><\/p>\n

We have the next question from the line of Amit Agarwal, an individual investor. Please go ahead.<\/p>\n

Unidentified Participant<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Manish Groverji<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Operator<\/strong><\/p>\n

Thank you. We have the next question from line of Mohan Agarwal [Phonetic], an investor. Please go ahead.<\/p>\n

Unidentified Participant<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Manish Groverji<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Operator<\/strong><\/p>\n

Thank you very much. Mohan, I’ll request to come back for a follow-up question. Next question is from line of Samip Barlota [Phonetic] from Techno Funda. Please go ahead.<\/p>\n

Unidentified Participant<\/strong><\/p>\n

[Speech Overlap] Good, congratulations. This is the Entero part, right?<\/p>\n

Manish Groverji<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Unidentified Participant<\/strong><\/p>\n

Okay. Sir, all the best for the great Q3, congratulations.<\/p>\n

Operator<\/strong><\/p>\n

Thank you very much. Ladies and gentlemen, that will be the last question for today. I’ll now hand the conference over to the management for closing comments.<\/p>\n

Manish Groverji<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Operator<\/strong><\/p>\n

Sir, that was the last question. You can go ahead for the closing comments.<\/p>\n

Manish Groverji<\/strong><\/p>\n

Yes, sir. Thank you. [Speech Overlap]<\/p>\n

Operator<\/strong><\/p>\n

Yes, sir.<\/p>\n

Manish Groverji<\/strong><\/p>\n

[Speech Overlap]<\/p>\n

Operator<\/strong><\/p>\n

Thank you very much. On behalf of Nuvama Wealth, that concludes this conference. Thank you for joining us and you may now disconnect your lines. Thank you.<\/p>\n","protected":false},"excerpt":{"rendered":"

Jeena Sikho Lifecare Ltd (NSE: JSLL) Q3 2026 Earnings Call dated Feb. 09, 2026 Corporate Participants: Manish Groverji \u2014 Managing Director Nanak Chand \u2014 Chief Financial Officer Analysts: Ranvir Singh \u2014 Analyst Priyanshu Jain \u2014 Analyst Akshay Kaila \u2014 Analyst Abhishek Sengupta \u2014 Analyst Akhilesh Rawat \u2014 Analyst Unidentified Participant Praveen Kumar \u2014 Analyst Deepak […]<\/p>\n","protected":false},"author":2377,"featured_media":147581,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[6349],"tags":[10169,9175,9104,9092,14492,10089],"class_list":["post-181549","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-transcripts","tag-earnings","tag-earnings-call","tag-earnings-conference","tag-earnings-transcripts","tag-financial-results","tag-quarterly-earnings"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":170237,"url":"https:\/\/alphastreet.com\/india\/jeena-sikho-life-care-q1-fy26-earnings-results\/","url_meta":{"origin":181549,"position":0},"title":"Jeena Sikho Life Care Q1 FY26 Earnings Results","author":"Divyansh_Kasana","date":"August 15, 2025","format":false,"excerpt":"Jeena Sikho Lifecare Limited is one of the leading providers of ayurvedic healthcare systems in India, delivering healthcare services for over a decade. Presenting below are its Q1 FY26 Earnings Results. Q1 FY26 Earnings Results Revenue: \u20b93,401 crore, up 4.23% year-on-year (YoY) from \u20b93,263 crore in Q1 FY25. Total Expenses:\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"JSLL Q1 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/JSLL.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/JSLL.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/JSLL.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/JSLL.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/JSLL.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/JSLL.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":180003,"url":"https:\/\/alphastreet.com\/india\/jeena-sikho-lifecare-limited-reports-sharp-q3-fy26-growth-as-revenue-and-profit-surge\/","url_meta":{"origin":181549,"position":1},"title":"Jeena Sikho Lifecare Limited reports sharp Q3 FY26 growth as revenue and profit surge","author":"Staff Correspondent","date":"February 9, 2026","format":false,"excerpt":"Jeena Sikho Lifecare Limited (NSE: JSLL, BSE: 544476) reported strong financial and operating performance for the quarter ended December 31, 2025, driven by rapid expansion across its Ayurveda healthcare services and products businesses, according to the company\u2019s Q3 FY26 investor presentation. Financial performance Revenue from operations rose to \u20b9221.66 crore\u2026","rel":"","context":"In "LATEST"","block_context":{"text":"LATEST","link":"https:\/\/alphastreet.com\/india\/category\/latest\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/10\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/10\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/10\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":173446,"url":"https:\/\/alphastreet.com\/india\/jeena-sikho-lifecare-ltd-jsll-q4-2025-earnings-call-transcript\/","url_meta":{"origin":181549,"position":2},"title":"Jeena Sikho Lifecare Ltd (JSLL) Q4 2025 Earnings Call Transcript","author":"News desk","date":"January 22, 2026","format":false,"excerpt":"Jeena Sikho Lifecare Ltd (NSE: JSLL) Q4 2025 Earnings Call dated May. 20, 2025 Corporate Participants: Manish Grover \u2014 Managing Director Nanak Chand \u2014 Chief Financial Officer Analysts: Ranvir Singh \u2014 Analyst Agastya Dave \u2014 Analyst Abhishek \u2014 Analyst Akshay Kaila \u2014 Analyst Naveen Baid \u2014 Analyst Prerana Nireeksha Amanna\u2026","rel":"","context":"In "Earnings Call Transcripts"","block_context":{"text":"Earnings Call Transcripts","link":"https:\/\/alphastreet.com\/india\/category\/transcripts\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":173447,"url":"https:\/\/alphastreet.com\/india\/jeena-sikho-lifecare-ltd-jsll-q2-2025-earnings-call-transcript\/","url_meta":{"origin":181549,"position":3},"title":"Jeena Sikho Lifecare Ltd (JSLL) Q2 2025 Earnings Call Transcript","author":"News desk","date":"January 22, 2026","format":false,"excerpt":"Jeena Sikho Lifecare Ltd (NSE: JSLL) Q2 2025 Earnings Call dated Nov. 13, 2024 Corporate Participants: Manish Grover \u2014 Managing Director Nanak Chand \u2014 Chief Financial Officer Analysts: Ranvir Singh \u2014 Analyst Sagar Jain \u2014 Individual Investor Sumit Gupta \u2014 |Analyst Chirag Shah \u2014 Analyst Yash Gandhi \u2014 Analyst Prerana\u2026","rel":"","context":"In "Earnings Call Transcripts"","block_context":{"text":"Earnings Call Transcripts","link":"https:\/\/alphastreet.com\/india\/category\/transcripts\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":109778,"url":"https:\/\/alphastreet.com\/india\/infosys-limited-infy-q4-2021-earnings-call\/","url_meta":{"origin":181549,"position":4},"title":"Infosys Limited (INFY) Q4 2021 Earnings Call","author":"Sahil Anand","date":"April 21, 2021","format":false,"excerpt":"Infosys Limited (NYSE: INFY) Q4 2021 earnings call dated\u00a0Apr. 14, 2021 Corporate Participants: Sandeep Mahindroo\u00a0\u2014\u00a0Vice President, Financial Controller & Head \u2013 Investor Relations Salil Parekh\u00a0\u2014\u00a0Chief Executive Officer and Managing Director Pravin Rao\u00a0\u2014\u00a0Chief Operating Officer and Whole-time Director Nilanjan Roy\u00a0\u2014\u00a0Chief Financial Officer Analysts: Ankur Rudra\u00a0\u2014\u00a0JPMorgan \u2014 Analyst Diviya Nagarajan\u00a0\u2014\u00a0UBS \u2014 Analyst\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/04\/Infosys-Limited-Q4-2021-Earnings-Call.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/04\/Infosys-Limited-Q4-2021-Earnings-Call.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/04\/Infosys-Limited-Q4-2021-Earnings-Call.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/04\/Infosys-Limited-Q4-2021-Earnings-Call.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/04\/Infosys-Limited-Q4-2021-Earnings-Call.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/04\/Infosys-Limited-Q4-2021-Earnings-Call.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":142292,"url":"https:\/\/alphastreet.com\/india\/kpr-mill-ltd-kprmill-q3-fy23-earnings-concall-transcript\/","url_meta":{"origin":181549,"position":5},"title":"KPR MILL LTD (KPRMILL) Q3 FY23 Earnings Concall Transcript","author":"IRS_INDIA","date":"February 21, 2023","format":false,"excerpt":"KPR MILL LTD (NSE:KPRMILL) Q3 FY23 Earnings Concall dated Feb. 7, 2023. Corporate Participants: P L Murugappan\u00a0--\u00a0Chief Financial Officer Analysts: Abhishek Nigam\u00a0--\u00a0B&K SECURITIES -- Analyst Kapil Jagasia\u00a0--\u00a0Nuvama -- Analyst Muthu Kumar\u00a0--\u00a0Fidelity Ventures -- Analyst Unidentified Participant\u00a0--\u00a0-- Analyst Presentation: Operator Ladies and gentlemen, good day and welcome to the KPR Mill\u2026","rel":"","context":"In "Consumer"","block_context":{"text":"Consumer","link":"https:\/\/alphastreet.com\/india\/category\/consumer-stocks\/"},"img":{"alt_text":"Earnings Conference Call Transcript","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/09\/Transcript-thumbnail-e1657213425955.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/09\/Transcript-thumbnail-e1657213425955.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/09\/Transcript-thumbnail-e1657213425955.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/181549","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/2377"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=181549"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/181549\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/147581"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=181549"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=181549"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=181549"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}